An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
University of Washington, Seattle, Washington, USA. sachsmc@u.washington.edu
Authors
Brunzell JD, Cleary PA, de Boer IH, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Hoofnagle AN, Lachin JM, Molitch ME, Sachs MC, Steffes MW, Zinman B
Studies
Citation
Sachs MC, Brunzell JD, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Zinman B, de Boer IH, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care 2013 Aug;36(8):2423-9. Epub 2013 Mar 25.Abstract
People with type 1 diabetes are at high risk of premature atherosclerosis. Existing evidence suggests that impaired vitamin D metabolism may contribute to the development of atherosclerosis. We tested associations of circulating vitamin D metabolite concentrations with subclinical atherosclerosis among 1,193 participants with type 1 diabetes in the DCCT/EDIC study.